HIMCH
BIO icon

Hartford Investment Management Co (HIMCO)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,285
Closed -$351K – 497
2024
Q2 		$351K Sell
1,285
-57
-4% -$16.6K 0.01% 492
2024
Q1 		$464K Sell
1,342
-59
-4% -$19.4K 0.02% 490
2023
Q4 		$452K Sell
1,401
-32
-2% -$10K 0.02% 487
2023
Q3 		$514K Sell
1,433
-91
-6% -$35.1K 0.02% 484
2023
Q2 		$578K Sell
1,524
-305
-17% -$124K 0.02% 483
2023
Q1 		$876K Buy
1,829
+265
+17% +$124K 0.03% 451
2022
Q4 		$658K Sell
1,564
-481
-24% -$194K 0.02% 476
2022
Q3 		$853K Sell
2,045
-9
-0.4% -$4.49K 0.03% 463
2022
Q2 		$1.02M Buy
2,054
+46
+2% +$24K 0.03% 447
2022
Q1 		$1.13M Sell
2,008
-184
-8% -$111K 0.03% 450
2021
Q4 		$1.66M Buy
2,192
+178
+9% +$133K 0.04% 404
2021
Q3 		$1.5M Sell
2,014
-257
-11% -$193K 0.04% 398
2021
Q2 		$1.46M Sell
2,271
-84
-4% -$51.1K 0.04% 416
2021
Q1 		$1.34M Sell
2,355
-106
-4% -$62.8K 0.04% 436
2020
Q4 		$1.44M Buy
2,461
+192
+8% +$109K 0.04% 399
2020
Q3 		$1.17M Sell
2,269
-74
-3% -$37.5K 0.04% 385
2020
Q2 		$1.06M Buy
+2,343
New +$1.03M 0.04% 392

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s BIO Position: Q3 2024 in Review

Hartford Investment Management Co (HIMCO) sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 1,285 shares — an estimated $351K sold.

Hartford Investment Management Co (HIMCO) first reported a position in BIO in Q2 2020 and held it in 17 quarters. The position peaked at $1.66M in Q4 2021. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Hartford Investment Management Co (HIMCO) reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 1,285 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $351K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 17 quarters.
  • Hartford Investment Management Co (HIMCO)'s Bio-Rad Laboratories Class A position peaked at $1.66M in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q3 2024, filed 22 Oct 2024.